To characterize the fecal microbiome of adult Ugandans living with HIV and assess its association with ART duration, CD4+ T cell counts, and intestinal parasite infections, focusing on how these factors influence gut health.
Key Findings:
Lower alpha diversity observed in PLHIV compared to HIV-uninfected individuals, indicating potential health risks.
Altered fecal microbiome composition in PLHIV, including overgrowth of Bacterioides uniformis and Prevotella copri, which may contribute to inflammatory conditions.
Persistent dysbiosis noted even after ART initiation, with changes in gut microbiome linked to immune status, suggesting implications for treatment efficacy.
Interpretation:
The study highlights the significant impact of HIV on gut microbiome composition, which may have implications for immune recovery and overall health in PLHIV, potentially guiding future treatment strategies.
Limitations:
Limited geographical scope to a single clinic in Uganda may affect generalizability and introduce selection bias.
Cross-sectional design limits causal inferences regarding microbiome changes over time, necessitating longitudinal studies.
Conclusion:
The findings underscore the need for further research on the gut microbiome in PLHIV, particularly in African contexts, to inform treatment and management strategies, including the exploration of dietary and environmental factors.
